Ecnoglutide is an investigational clinical program.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Ecnoglutide is an investigational clinical program. No seller listing in India can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Resolve the exact identity of Ecnoglutide through SLIMMER Phase 3 study - NCT05813795 from ClinicalTrials.gov. Then search Approved new drugs from Central Drugs Standard Control Organization for the destination product record and Drug and quality alerts from Central Drugs Standard Control Organization for the seller, establishment, or supply route in India. A match in one record does not replace the other two checks.
No. A page using the name Ecnoglutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. Ecnoglutide injection has NMPA approvals in China for adult type 2 diabetes and chronic weight management in Chinese adults with overweight or obesity. Those China-specific approvals do not establish FDA approval, authorization in another country, or the identity and authority of an online seller. For India, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
The current registry snapshot contains no Ecnoglutide study record with a listed India location. This is a dated search result, not proof that a study cannot be added later.
Registry update: 24 July 2026The current registry snapshot contains no Ecnoglutide study record with a listed India location. This is a dated search result, not proof that a study cannot be added later.
ClinicalTrials.gov search ↗Ecnoglutide is an investigational clinical program. No seller listing in India can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Primary identity source: SLIMMER Phase 3 study - NCT05813795 / ClinicalTrials.gov ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
SLIMMER Phase 3 study - NCT05813795 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open SLIMMER Phase 3 study - NCT05813795 ↗Approved new drugs is maintained by Central Drugs Standard Control Organization. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Approved new drugs ↗Drug and quality alerts is maintained by Central Drugs Standard Control Organization. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Drug and quality alerts ↗India's medicine oversight combines central responsibilities with state licensing and enforcement. CDSCO publishes new-drug approvals and quality or spurious-product alerts, but neither list by itself verifies a clinic, pharmacy, imported research listing, or local seller claim.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Search CDSCO's approved new-drug records for the exact name and approval period. Do not treat a foreign authorization, sponsor announcement, or ingredient match as an Indian approval entry.
Check CDSCO alerts for not-of-standard-quality and spurious batches. An approval record and a later batch alert answer different questions and both may matter.
Pharmacy and sale permissions may depend on the relevant State Drug Control authority, so match the business and jurisdiction instead of assuming a central product entry verifies the seller.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.